• Search
  • Advanced Search

Search

  • HOME
  • Search
Original Article
Clinical Evaluation of Congenital Heart Disease in Down Syndrome.
Sang Kyu Park, Young Hoon Kim, Son Moon Shin, Chung Il Noh, Jung Yun Choi, Yong Soo Yun, Cang Yee Hong, Kyoo Wan Choi, Shin Yong Moon
Clin Exp Pediatr. 1986;29(10):1095-1103.   Published online October 31, 1986
The association of congenital heart disease in patients with Down syndrome has been recognized for nearly 100 years. A wide variety of congenital heart diseases have been identified in these patients. This is the report of clinical evaluation of 105 patients with congenital heart disease in Down syndrome, experienced at the Seoul National University Hospital, during past 6 years from Jan. 1980...
Superoxide Dismutase Activity in Down Syndrom.
Moon Sook Lee, Hae Woon Chang, Kun Soo Lee, Ja Hoon Koo, Kun Young Sohn
Clin Exp Pediatr. 1986;29(4):361-374.   Published online April 30, 1986
Superoxide dismutase activity of erythrocyte in 20 cases of 21-trisomy Down syndrome between 2 months and 15 years old age and 13 cases of age-matched normal children were checked at Department of Pediatrics and Department of Biochemistry, School of Medicine, Kyung-Pook National University. The results were following: Mean superoxide dismutase activity in normal children was 202.25 U/gmHb and in Down syndrome 291.69 U/gmHb, and the ratio...
Case Report
A Case of Trensient Myeloproliferative Disorder with Down Syndrome.
Dong Gyoon Kim, Jae Ho Lee, Jung Il Noh, Hyo Seop Ahn, Chang Yee Hong
Clin Exp Pediatr. 1983;26(10):1024-1028.   Published online October 31, 1983
Transient myeloproliferative disorder has been reported in infants with Down syndrome. Infants with Down syndrome and this transient myeloproliferative disorder often present with signs and symptoms that are clinically and hematologically indistinguishable from congenital acute myelogenous leukemia. In contrast to congenital AML, complete clinical and hematological recovery occurs within weeks to months of diagnosis without any specific anti- leukemic treatment. A case of transient myeloproliferative disorder...